微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.24% | 106.94% | 101.41% | 103/158 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -16.97% | 67.15% | -4342.5% | 130/158 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 0.4% | 102.95% | 113.33% | 110/158 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -3% | 46.81% | 13.29% | 129/158 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -3.46% | -2406.67% | 93.3% | 134/158 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -51.66% | -18550% | -280.69% | 144/158 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -13.57% | -722.48% | -140.6% | 136/158 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -5.64% | -380.6% | -3860% | 127/158 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.15% | -84.38% | -46.43% | 115/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 0.28% | -96.32% | -87.16% | 108/158 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.18% | -68.95% | 8.46% | 94/158 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.01% | -61.49% | 109.38% | 84/158 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.96% | -59.66% | -87.37% | 92/158 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 7.6% | -14.99% | 8.26% | 59/158 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 7.02% | -3.31% | 34.48% | 61/158 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.22% | 11.54% | 119.33% | 53/158 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.38% | 33.71% | -73.38% | 57/158 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 8.94% | 8.1% | 23.14% | 64/158 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 7.26% | -2.68% | 55.13% | 55/158 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 4.68% | 3.08% | 162.92% | 58/158 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.78% | -20.18% | -78.48% | 53/158 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 8.27% | 49.01% | 10.86% | 67/158 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 7.46% | 12.01% | 64.32% | 48/158 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.54% | 5.09% | 103.59% | 53/158 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.23% | 17.37% | -59.82% | 52/158 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 5.55% | -33.05% | -16.67% | 81/158 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 6.66% | 14.83% | 54.17% | 49/158 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.32% | 18.68% | 127.37% | 50/158 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.9% | -0.52% | -77.08% | 57/158 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 8.29% | -10.86% | 42.93% | 61/158 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.8% | -10.36% | 59.34% | 59/158 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 3.64% | -14.75% | 90.58% | 66/158 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.91% | 1.06% | -79.46% | 44/158 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 9.3% | -8.46% | 43.74% | 61/158 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 6.47% | 17% | 51.52% | 41/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 4.27% | 11.2% | 125.93% | 43/158 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.89% | 23.53% | -81.4% | 41/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 10.16% | 6.28% | 83.73% | 49/158 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 5.53% | 0% | 44.01% | 45/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 3.84% | -8.13% | 150.98% | 47/158 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 1.53% | -13.07% | -84% | 46/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |